SCHEMBL798970

SCHEMBL798970

COc1cccc(C(=O)C2CN(F)CCN2c2nc(N)nc(N)c2N)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.42
KDM2B Q8NHM5 3/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 3/20 0.38
HSD11B1 P28845 1/20 0.38
HPGD P15428 1/20 0.38
NEK2 P51955 1/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
PARP1 P09874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL655783 0.84 DHFR (0.38) DHFRKDM2BKMT2AMEN1NPSR1
SCHEMBL798809 0.76 GAA (0.39) DHFRKDM2BKMT2AMEN1ALDH1A1
SCHEMBL656125 0.67 FPR2 (0.40) KDM2BKMT2AMEN1NPSR1L3MBTL1
SCHEMBL3188892 0.65 UBE2M (0.51) L3MBTL1ALDH1A1HSD11B1HPGDKDM4E
SCHEMBL26698259 0.64 KDM2B (0.57) KDM2BKMT2AMEN1NPSR1ALDH1A1
SCHEMBL4776118 0.64 KDM2B (0.51) KDM2BKMT2AMEN1ALDH1A1HSD11B1
SCHEMBL7309424 0.63 CES2 (0.65) KDM2BKMT2AMEN1HSD11B1SMN1; SMN2
SCHEMBL31636008 0.63 CES2 (0.65) KDM2BKMT2AMEN1HSD11B1SMN1; SMN2
SCHEMBL5210032 0.62 MGLL (0.62) KDM2BKMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL30771226 0.62 MGLL (0.62) KDM2BKMT2AMEN1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed